The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSerica Energy Regulatory News (SQZ)

Share Price Information for Serica Energy (SQZ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 203.20
Bid: 204.40
Ask: 204.60
Change: -3.40 (-1.65%)
Spread: 0.20 (0.098%)
Open: 208.80
High: 210.00
Low: 203.20
Prev. Close: 206.60
SQZ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - Serica Energy plc

14 Jul 2022 12:00

RNS Number : 5095S
Kistos PLC
14 July 2022
 

KISTOS PLC

 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Kistos plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Serica Energy plc

(d) Is the discloser the offeror or the offeree?

Offeror

(e) Date position held:

The latest practicable date prior to the disclosure

13 July 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

 

 

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

 

 

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

· The Directors of Kistos plc have the following interests in Serica Energy plc ordinary shares, which in aggregate represent approximately 0% of the issued ordinary share capital of Serica Energy plc.

 Name

Position

Number of Kistos ordinary shares beneficially held

Percentage of Kistos issued ordinary share capital

Number of Kistos ordinary shares over which options are held

Andrew Philip Austin

Executive Chairman; Director

-

-

-

Julie Barlow

Non-Executive Director

-

-

-

Richard Alan Benmore

Non-Executive Director

-

-

-

Alan Booth

Non-Executive Director

-

-

-

Peter George Mann

Chief Executive Officer; Director

-

-

-

Richard Slape

Chief Financial Officer; Director

-

-

-

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

No

Supplemental Form 8 (SBL)

No

 

 

Date of disclosure:

14 July 2022

Contact name:

Richard Slape

Telephone number:

+44 (0)20 4531 2800

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEBKQBPKBKDCOD
Date   Source Headline
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:01 amRNSInitiation of share buyback programme
24th Apr 20247:00 amRNSFinal Results
16th Apr 20242:00 pmRNSResults Date/Investor Presentation/CEO Change Date
26th Mar 202411:08 amRNSIssue of Shares and Total Voting Rights
7th Mar 20245:06 pmRNSPDMR Dealings
7th Mar 202411:35 amRNSPDMR Dealings
7th Mar 20247:00 amRNS2023 Year End Reserves and 2024 Production Update
29th Feb 20244:30 pmRNSTotal Voting Rights
26th Feb 20247:00 amRNSAcquisition of Interest in Greater Buchan Area
8th Feb 202411:32 amRNSPDMR Dealings
8th Feb 20247:00 amRNSPresentation to Sell-Side Analysts
7th Feb 20246:09 pmRNSPDMR Dealings
6th Feb 20246:17 pmRNSPDMR Dealings
5th Feb 20247:00 amRNSOperations Update
1st Feb 20242:25 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNSChief Executive Officer change and Succession Plan
23rd Jan 20247:00 amRNSCompletion of New 6-year Borrowing Facility
29th Dec 20237:00 amRNSTotal Voting Rights
20th Dec 20231:25 pmRNSBLOCK LISTING SIX MONTHLY RETURN
20th Dec 20231:20 pmRNSBLOCK LISTING SIX MONTHLY RETURN
20th Dec 20231:15 pmRNSBLOCK LISTING SIX MONTHLY RETURN
20th Dec 20231:10 pmRNSBLOCK LISTING SIX MONTHLY RETURN
18th Dec 20237:00 amRNSNew US$525 million 6-year Borrowing Facility
6th Dec 20237:00 amRNSOperations and Organisation Update
30th Nov 20234:15 pmRNSTotal Voting Rights
23rd Nov 20237:00 amRNSAcquisition of Interest in Greater Buchan Area
21st Nov 20237:00 amRNSBoard Changes
31st Oct 20233:40 pmRNSTotal Voting Rights
31st Oct 20237:00 amRNSUKCS 33rd Round Licence Award
28th Sep 20232:10 pmRNSHolding(s) in Company
27th Sep 20234:30 pmRNSHolding(s) in Company
26th Sep 20232:50 pmRNSHolding(s) in Company
25th Sep 20234:32 pmRNSHolding(s) in Company
22nd Sep 20232:16 pmRNSIssue of Shares and Total Voting Rights
20th Sep 20237:00 amRNSHolding(s) in Company
19th Sep 20237:00 amRNSInterim Results
8th Sep 202311:25 amRNSNotice of Results and Investor Presentation
31st Aug 202311:56 amRNSTotal Voting Rights
25th Aug 20237:00 amRNSBlock Listing Six Monthly Return
18th Aug 20239:05 amRNSBlock Listing Six Monthly Return
16th Aug 20237:06 amRNSBLOCK LISTING SIX MONTHLY RETURN
11th Aug 20234:10 pmRNSBlock Listing Six Monthly Return
8th Aug 20239:40 amRNSBlock Listing Application
31st Jul 202312:55 pmRNSTotal Voting Rights
17th Jul 20239:54 amRNSBoard Changes
30th Jun 202312:12 pmRNSTotal Voting Rights
29th Jun 20232:30 pmRNSResult of AGM
29th Jun 20237:00 amRNSCorporate Presentations for AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.